Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2010
03/24/2010CN101679398A Nicotinamide derivatives as synthesis units for producing agrochemical substances, and method for the production thereof
03/24/2010CN101679397A Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity
03/24/2010CN101679379A arylamide pyrimidone compounds
03/24/2010CN101679377A Heterocyclic hydrazide compound and pesticidal use of the same
03/24/2010CN101679375A 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
03/24/2010CN101679371A Substituted pyrimidines as adenosine receptor antagonists
03/24/2010CN101679368A aryloxazole, aryloxadiazole and benzimidazole derivatives
03/24/2010CN101679366A pyridyl piperidine orexin receptor antagonists
03/24/2010CN101679361A Certain substituted amides, method of making, and method of use thereof
03/24/2010CN101679359A Quinolines and their therapeutic use
03/24/2010CN101679357A Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/24/2010CN101679354A Novel triazinedione derivatives as GABAB receptor modulators
03/24/2010CN101679351A Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor
03/24/2010CN101679348A 5-pyridinone substituted indazoles
03/24/2010CN101679324A 吗啉衍生物 Morpholine derivatives
03/24/2010CN101679303A pyridazinone derivatives
03/24/2010CN101679287A nicotinic acetylcholine receptor modulators
03/24/2010CN101679270A dihydroquinone and dihydronaphthridine inhibitors of jnk
03/24/2010CN101679264A inhibitors of focal adhesion kinase
03/24/2010CN101679258A 4 -pi peridinylurea compounds as soluble epoxide hydrolase inhibitors
03/24/2010CN101679239A inhibitors of histone deacetylase
03/24/2010CN101678215A Sulfonyl amide derivatives for the treatment of abnormal cell growth
03/24/2010CN101678214A 芳基醚哒嗪酮衍生物 Aryl ether pyridazinones
03/24/2010CN101676284A Preparation method of nifuratel with high purity
03/24/2010CN101676271A Tetracycline derivatives containing unsaturated heterocyclic amine
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683082 1,2,4-oxadiazole benzoic acid compositions and their use in bioassays
03/23/2010US7683081 arthritis, allergic contact dermatitis, psoriasis, asthma, rheumatoid arthritis, or stroke; using producing coronary vasodilation without significant peripheral vasodilation
03/23/2010US7683070 insecticides for soil-borne insects, such as termites and white grubs; less costly and safer to use on crops; N-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methylene}piperidyl)methyl]phenyl}ethoxycarboxamide, N-oxide
03/23/2010US7683069 3-substituted-4-pyrimidone derivatives
03/23/2010US7683067 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)
03/23/2010US7683063 inhibiting Vanilloid Receptor 1; Inflammatory bowel disease; Crohn's disease and ulcerative colitis; cyclo(hetero)alkenyl compound
03/23/2010US7683059 Triazole compounds and uses related thereto
03/23/2010US7683057 Kinase inhibitor compounds
03/23/2010CA2465686C Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine)
03/23/2010CA2460177C 3-substituted-4-pyrimidone derivatives
03/23/2010CA2395603C Linezolid-crystal form ii
03/23/2010CA2377278C Prodrugs of carbamate inhibitors of impdh
03/18/2010WO2010030722A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
03/18/2010WO2010030592A1 Compounds for the treatment of hepatitis c
03/18/2010WO2010029927A1 Aromatic compound
03/18/2010WO2010029926A1 Lighting cover
03/18/2010WO2010029299A1 Pyrimidinone derivaties for use as medicaments
03/18/2010WO2010007382A8 Benzazepine derivatives and their use as hstamine h3 antagonists
03/18/2010US20100069643 Convergent Process for the Synthesis of Taxane Derivatives
03/18/2010US20100069638 Sulfonamide derivative having pgd2 receptor antagonistic activity
03/18/2010US20100069629 Pyrimidine derivatives as pi3k inhibitor and use thereof
03/18/2010US20100069449 Novel oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient
03/18/2010US20100069441 Antimicrobial indoline compounds for treatment of bacterial infections
03/18/2010US20100069414 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
03/18/2010US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
03/18/2010US20100069388 N-hydroxyacrylamide compounds
03/18/2010US20100069384 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy
03/18/2010US20100069383 Compounds and therapeutical use thereof
03/18/2010US20100069381 Gsk-3betainhibitor
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100069378 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
03/18/2010US20100069375 Indolone-Acetamide Derivatives, Processes for Preparing Them and Their Uses
03/18/2010US20100069369 Kinase Inhibitors And Their Uses
03/18/2010US20100069367 LXR and FXR Modulators
03/18/2010US20100069361 Fused Thiazole Derivatives as Kinase Inhibitors
03/18/2010US20100069358 Use of 7-azaindoles in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069354 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069353 Inhibitors of hiv replication
03/18/2010US20100069346 New Azetidine Derivatives as Neurokinin Receptor Antagonists for the Treatment of Gastrointestinal Diseases
03/18/2010US20100066244 Compound having oxadiazole ring structure substituted with pyridyl group and organic electroluminescence device
03/18/2010CA2736988A1 Compounds for the treatment of hepatitis c
03/18/2010CA2736970A1 Pyrimidinone derivatives for use as medicaments
03/17/2010EP2163546A1 Quinazoline derivatives
03/17/2010EP2162433A2 4' substituted compounds having 5-ht6 receptor affinity
03/17/2010EP2161997A1 Tricyclic inhibitors of fatty acid amide hydrolase
03/17/2010EP1713822B1 Hcv ns-3 serine protease inhibitors
03/17/2010EP1689742B1 Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
03/17/2010EP1654257B1 Aminopyrones and their use as atm inhibitors
03/17/2010EP1620411B1 Inhibitors of akt activity
03/17/2010EP1572214B1 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
03/17/2010EP1347955B1 New mandelic acid derivatives and their use as throbin inhibitors
03/17/2010CN101675041A Aminopyrimidines useful as kinase inhibitors
03/17/2010CN101675034A Pyridone derivatives as p38a mapk inhibitors
03/17/2010CN101674727A Pyridonecarboxamides crop protection agents containing the same method for production and use thereof
03/17/2010CN101671307A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
03/17/2010CN101669952A Pyridazine derivatives and their use as therapeutic agents
03/16/2010US7680601 Generating antibiotic; transforming cell with expression vector coding polyketide synthase; computational analysis of polyketides and computer-assisted design of PKS genes are facilitated by representing structure of polyketide and/or PKS gene that encodes PKS that produces polyketide
03/16/2010US7678911 1,6 naphthyridines useful as inhibitors of SYK kinase
03/16/2010US7678904 or to treat autoimmune and inflammatory disorders; improved water solubility characteristics
03/16/2010US7678825 Administering 2-[1-(3-Ethoxy-4-methoxyphenyl)2-methylsulfonylethyl]4,5-diaminoisoindoline-1,3-dione or salts to treat Crohn's disease, inflammatory bowel disease, psoriasis, rheumatoid arthritis, spondylitis, osteoarthritis, or ulcerative colitis; tumor necrosis factor and phosphodiesterase inhibitors
03/16/2010US7678813 8a-Benzyl-2-(4-methoxyphenyl)-1,3,4,7,8,8a-hexahydro-2H-isoquinolin-6-one; psychotic major depression, schizoaffective disorder, Alzheimer's Disease and cocaine addiction
03/16/2010US7678804 Pyrimidine derivatives for treatment of hyperproliferative disorders
03/16/2010US7678802 Voltage gated sodium and calcium channel inhibitors
03/16/2010US7678801 Compounds
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
03/16/2010US7678796 MGluR5 modulators I
03/16/2010US7678792 e.g. 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one; protein kinase inhibitor; antiinflammatory, anticarcinogenic, antiallergen, antidiabetic, antiischemic, hypotensive agent
03/16/2010US7678789 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
03/16/2010CA2500492C Aryl sulfonamides
03/16/2010CA2492467C Injectable depot formulation comprising crystals of iloperidone
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/11/2010WO2010028179A1 Heterocyclic compounds as gata modulators
03/11/2010WO2010028174A1 Novel biccyclic compounds as gata modulators
03/11/2010WO2010028159A2 Transition metal-catalyzed c-h amination using unactivated amines